The Effect of Targeted Therapy on Overall Survival in Advanced Renal Cancer: A Study of the National Surveillance Epidemiology and End Results Registry Database-Reference-Cited by-同舟云学术

The Effect of Targeted Therapy on Overall Survival in Advanced Renal Cancer: A Study of the National Surveillance Epidemiology and End Results Registry Database

Published:2014-04 Issue:2 Volume:12 Page:124-129
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Vaishampayan Ulka,Vankayala Hema,Vigneau Fawn D.,Quarshie William,Dickow Brenda,Chalasani Supraja,Schwartz Kendra

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference19 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

3. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy;Fyfe;J Clin Oncol,1995

4. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma;McDermott;J Clin Oncol,2005

5. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Intervention to Reduce Fear of Progression and Trauma Symptoms in Advanced Cancer Using Written Exposure to Worst-Case Scenarios;Journal of Palliative Medicine;2024-08-01

2. Racial and Ethnic Disparities in Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Receiving Immunotherapy;Clinical Genitourinary Cancer;2024-08

3. Management of arterial hypertension during therapy with antiangiogenic drugs in metastatic renal cell carcinoma;Medical alphabet;2023-10-23

4. Late recurrence of chromophobe renal cell carcinoma to unusual sites after 12 years of radical nephrectomy and radiotherapy: a rare case report from Syria;Annals of Medicine & Surgery;2023-03-25

5. Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States;Annals of Epidemiology;2023-03